Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials

Published:2005-06-17 Issue:7 Volume:21 Page:1123-1130
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Catapano Alberico,Brady William E.,King Thomas R.,Palmisano Joanne

Publisher

Informa Healthcare

Subject

General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1185/030079905X50642

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction;PLOS ONE;2022-08-30

2. The pharmacology of cholesterol-lowering drugs: The pharmacology of cholesterol-lowering drugs;European Atherosclerosis Journal;2022-04-05

3. LDL-Cholesterol-Lowering Therapy;Handbook of Experimental Pharmacology;2020

4. Possibilities of clinical use of ezetimibe Otrio (JSC “AKRIKHIN”, Russia) in patients with high and very high cardiovascular risk who have not reached the target values of lipid metabolism. Conclusion of the Board of experts;Kardiologiia;2019-06-20

5. Ezetimibe in the treatment of hypercholesterolaemia;Interní medicína pro praxi;2019-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP